India to Russia: Glucosamine Export Trade Route

The India to Russia Glucosamine corridor is one of India's established pharmaceutical export routes, with 64 shipments documented worth a combined $2.2M USD. The route is dominated by PANACEA BIOTEC PHARMA LIMITED, which alone accounts for roughly 75% of all export value, reflecting the consolidated nature of India's glucosamine manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $33.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with glucosamine's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 27.9%, placing it at rank #18 among India's top glucosamine export destinations globally.

On the import side, key buyers of Indian glucosamine in Russia include PANBIO PHARM LLC, PANBIO PHARM LLC , M S PANBIO PHARM LLC and 6 others. PANBIO PHARM LLC is the single largest importer with 31 shipments valued at $1.3M USD.

India's glucosamine exports to Russia are driven primarily by a handful of large-scale manufacturers. PANACEA BIOTEC PHARMA LIMITED with 36 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Russia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — PANACEA BIOTEC PHARMA LIMITED, PANACEA BIOTEC PHARMA LIMITED , PHRIA PHARMAOTECH PRIVATE LIMITED — together account for 95% of total trade value on this route. The average shipment value of $33.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as kondro nova capsules (glucosamine sulpha and kondro nova capsules (glucosamine sulpha, suggesting that buyers in Russia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, PANBIO PHARM LLC is the largest importer with 31 shipments worth $1.3M USD — representing 60% of all glucosamine imports from India on this route. A total of 9 buyers are active on this corridor.